Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/medicine-news/study-finds-lymphoma-drug-effective-over-long-term-21698-1/) was not found.

Search study finds lymphoma drug effective over long term at Google

Search study finds lymphoma drug effective over long term at Yahoo

Search study finds lymphoma drug effective over long term at Msn

Google
 
(Date:9/4/2008)...mber 2008 Even scientists define ,a gene, in diff...e media also have various ways of framing the conc...in the October 2008 issue of EMBO reports . , Th... of 300 articles in British and Norwegian newspape...the UK; and Aftenposten, Dagbladet, and VG from No...
(Date:9/4/2008)...p between Syracuse University and the Serum Instit...aving vaccines for children living in some of the ...te recently awarded $250,000 to a team of SU resea... chemistry in the College of Arts and Sciences, to...avirus, a severe form of diarrhea that affects inf...
(Date:9/4/2008)...covered a gene enhancer, known as HACNS1, that may... opposable human thumb, and possibly also modifica...lk on two legs, according to a paper published in ...first to provide evidence of the existence of huma... genes in the human genome. , Dr. Shyam Prabha...
(Date:9/4/2008)... The development of powerful supercomputers capabl...eye mark a technological milestone capable of brin...ngineering, and business worldwide. Researchers at...rine and Atmospheric Science, collaborating with N...LA (Center for Ocean-Land-Atmospheric Studies) and...
Breaking Biology News(10 mins):What is a gene? 2Syracuse University partners with Serum Institute of India to develop vaccines for children 2Syracuse University partners with Serum Institute of India to develop vaccines for children 3Syracuse University partners with Serum Institute of India to develop vaccines for children 4Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3Petascale climate modeling heats up at University of Miami 2Petascale climate modeling heats up at University of Miami 3Study shows drug effective in treating preventing breast cancer 5220 1Study shows drug effective in treating preventing breast cancer 5220 2Diabetes 3A A Top Cause of Blindness Among Adults 5216 1Diabetes 3A A Top Cause of Blindness Among Adults 5216 2Diabetes 3A A Top Cause of Blindness Among Adults 5216 3Agingcare com Launches to Meet Information and Networking Demands for Booming 34 Million Caregiver Market 5211 1Agingcare com Launches to Meet Information and Networking Demands for Booming 34 Million Caregiver Market 5211 2National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative 5206 1National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative 5206 2
...ct has heated up over the past year as more and mo...ogical responses to placebos. A new study takes pl...nical trial, showing a discernible placebo effect ...ritish Medical Journal. , While researchers usual...ectiveness of a new treatment, this trial pitted o...
...ng beneath the ocean surface that could help defin...inking. , A remote sensor system developed by Asso...neering, along with others at MIT, Northeastern Un... scientists to track enormous fish populations, or...quare-kilometer area - a vast improvement over con...
...nervous system relays information may hinge on how...t of neurotransmitter across a synapse to a recept... University of Illinois at Chicago biology profess... issue of the Proceedings of the National Academy ...field was solidly behind the idea that these littl...
...ision of Cellegy Pharmaceuticals, Inc. today annou...ch and develop Biosyn-patented microbicides for th... diseases. , The three microbicides covered und...ent and work under different mechanisms of action.... III clinical trials in the U.S. and Africa; UC781...
Other Biology News:All placebos not created alike 2One fish, two fish: New MIT sensor improves fish counts 2Protein receptor cools passion of 'kiss and run' nerve cells 2New licensing agreement to maximize AIDS drug development 2
(Date:9/5/2008)...odels are enhanced by taking into account risk fac... according to research teams led by epidemiologist... Center in two complementary papers appearing in t.... , In the first study to focus on African-Ameri...creased exposure to certain risks. Based upon thes...
(Date:9/4/2008)...e Medicare Advantage (MA) plans will be paid an av...red to what the same enrollee would have cost in t...ccording to a new report from The Commonwealth Fun...dated by the Medicare Improvements for Patients an... effect beginning in 2010 had been fully in place...
(Date:9/4/2008)...pancreatic tumors , , THURSDAY, Sept. 4 ...coveries involving genetic mutations of two deadly...reatic cancer -- may lead to new treatments and ev...present the most complete genetic analysis to date...map of these deadly cancers," Kenneth Kinzler, a p...
(Date:9/4/2008)...RNewswire/ -- Martin Schiff, M.D.,is an illustriou...weight,control and weight loss. His career is deta...he West," "Who,s Who in America," "Who,s Who in,th...and other honor rolls., Dr. Schiff recently retir...ate, misleading theories and notions concerning we...
Breaking Medicine News(10 mins):Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Genetic Mutations Linked to Deadly Cancers 2Health News:Genetic Mutations Linked to Deadly Cancers 3Health News:Genetic Mutations Linked to Deadly Cancers 4Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2
...alyzing the neuronal receptor activity in the post...ia, researchers at the University of Pennsylvania ...ists at the City University of New York, have foun...h level of erbB4 receptor activity and reduced NMD...
...a of subjecting drug addicts to shock therapy as a... debates and controversies. Now, the Scottish Exec...rapy //. Shock therapy technically labeled as Neu...with the use of self-adhesive electrodes inserted ...
...bane childcare center, a tuberculosis case alerts ...diagnosed in a childcare worker, who works at the ...Mount Ommaney in west Brisbane. Dr Michael Whitby... Medical Association (AMA) said that children’s (m...
...ast Victoria Sale Hospital's two pediatricians, Jo...ions with three months notice with three months no...xpected for at least six months. This has led to .... Sale obstetrician Dr Refaat Guirguis has said th...
Other Medicine News:Health News:Schizophrenia Complicates With Altered Receptor Activity 2Health News:Schizophrenia Complicates With Altered Receptor Activity 3
...al description: Humidity wells in the base hold 10... hydration around the edges of the coverslip. The ...ontamination. This chamber can be used with either...ovens. Linkage: This CLS number is a new product n...
...in DetectorTM Microarray Dot Blot Kits overcome th... and quantitation over a wide range in low-density...on. They are ideal for performing reverse-phase p...s for the presence of low abundant antigens. Prote...
...ATH™ Protein Microarray Slide features an ult...oassays. The,PATH™ Slide is the first protein...nitrocellulose in a thin film with low,background ...atios. ,The PATH™ Slide can be used for a va...
...lZyme AP Conjugate Stabilizer is an aqueous soluti...er non-toxic stabilizing chemicals in a MES buffer... This product contains a combination of 0.02% meth...reservative. StabilZyme AP Conjugate Stabilizer i...
Biology Products:
Delicate side cutting wire cutter with carbide inserts.
Curved osteotome for bone removing.
...t. It is created using the Panoramic200 and is use...ye and non-eye diseases and disorders. It is avail... non-reimbursable. The optomap provides the practi...tients retina which is viewed on-screen by the pra...
...amera is a state-of-the-art, office-based nuclear ...riendly gantry, and provides full sized fields of ...linic you need a flexible system that can work aro... Pulse reduces the costs of adding a gamma camera ...
Medicine Products:
(Date:9/5/2008)...swire/ -- Campbell Alliance, the leading,managemen...al and biotech,industry, today announced that lead...ing engagements at the Center for Business Intelli...arma Sales Model, to be held September,8 and 9, 20... An award-winning sales professional before becomi...
(Date:9/4/2008)...wswire-FirstCall/ -- Hologic, Inc.,(Nasdaq: HOLX ... Officer,will be presenting at the Morgan Stanley... September 9, 2008, at the Grand Hyatt Hotel in Ne...sten to a live audio webcast of,Hologic,s investor...35 PM.,Eastern Time on the investor section of th...
(Date:9/4/2008)...venues of $88.4 million, up 14% from the, prior y... an increase of, 47% over last year,s third quart...date operating cash flow of $62 million) - Raising...arnings guidance, COLUMBIA, Md., Sept. 4 /PRNewsw...Nasdaq: MATK ) today announced its financial resu...
(Date:9/4/2008)...wswire/ -- The Ohio State University,Medical Cente...iscuss,translating scientific breakthroughs in the...g the national Personalized Health Care Conference...policy makers, health care providers,researchers,...and patient,advocacy groups will be among the more...
Breaking Biology Technology:Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 2Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 3Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 4Hologic to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2Martek Announces Third Quarter 2008 Financial Results 2Martek Announces Third Quarter 2008 Financial Results 3Martek Announces Third Quarter 2008 Financial Results 4Martek Announces Third Quarter 2008 Financial Results 5Martek Announces Third Quarter 2008 Financial Results 6Martek Announces Third Quarter 2008 Financial Results 7Martek Announces Third Quarter 2008 Financial Results 8Martek Announces Third Quarter 2008 Financial Results 9Martek Announces Third Quarter 2008 Financial Results 10OSU to Host National Personalized Health Care Conference 2
...on, Wis. - In an attempt to measurably increase t...ies, the state Department of Financial Institutio...g the creation of a Venture Capital Center. , ,Lor...objective is to encourage institutional investors ...ecome limited partners in regional venture capital...
...on, Wis. - In an effort to spur entrepreneurship ...Kauffman Foundation has named the University of ...ampuses," and the university has received $5 milli...The Kauffman Foundation launched the campus initia...o a wider range of students and extend the reach o...
... folks, this is my last article of the year, and I...ars past, so my New Year,s resolution for this col...blue, rock, or folk-related). Part of the problem ... this past year, or bought many new CDs (something..., my focus has been more on biotech,s internationa...
...on, Wis. - Third Wave Technologies, Inc . has si...hat could provide it with $14.9 million through th...company plans to use the proceeds for general corp...otes are convertible into approximately 2.48 milli...sion price of $6 per share. The notes carry a yiel...
Other Biology Technology:State agencies propose venture capital center 2UW gets $5M to extend entrepreneurship 22006: A great biotech financing year, unless you were going public! 22006: A great biotech financing year, unless you were going public! 32006: A great biotech financing year, unless you were going public! 42006: A great biotech financing year, unless you were going public! 5
(Date:9/5/2008)... SOUTH SAN FRANCISCO, Calif., Sept. 5 /PRNewswir...pany focused on small molecule LFA-1 inhibitors,to...uticals, Inc. (Nasdaq:,SNSS) today announced SARco...mall molecule LFA-1 product candidate for T-cell m...ntered into a license agreement providing,SARcode ...
(Date:9/4/2008)... MELBOURNE, Australia, Sept. 4 /- C...is commencing enrolment for its Phase Ib/II,study ... anticancer agent,in patients with an aggressive ...rme (GBM)., The GBM clinical trial is the first P...umor indications for the company and the second in...
(Date:9/4/2008)...Another Roche first in TaqMan(R) real-time PCR tes... lab, PLEASANTON, Calif., Sept. 4 /PRNewswi...as approved the Roche COBAS(R) TaqMan(R) HBV Test,...s DNA approved in the U.S.,The test uses Roche,s r...Hepatitis B virus DNA in a patient,s blood. Doctor...
(Date:9/4/2008)... BIRMINGHAM, Ala., Sept. 4 /- South...tional Institutes of Health (NIH) has selected,the...olecular Libraries,Probe Production Center Network...twork -- is part of the Molecular Libraries Progra...en scientific knowledge of the human,genome and va...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Kaiser Permanente CEO Receives Diversity Leadership Award 5201 1Kaiser Permanente CEO Receives Diversity Leadership Award 5201 2United Therapeutics Reports Third Quarter 2007 Financial Results 1642 1United Therapeutics Reports Third Quarter 2007 Financial Results 1642 2United Therapeutics Reports Third Quarter 2007 Financial Results 1642 3United Therapeutics Reports Third Quarter 2007 Financial Results 1642 4United Therapeutics Reports Third Quarter 2007 Financial Results 1642 5United Therapeutics Reports Third Quarter 2007 Financial Results 1642 6United Therapeutics Reports Third Quarter 2007 Financial Results 1642 7United Therapeutics Reports Third Quarter 2007 Financial Results 1642 8United Therapeutics Reports Third Quarter 2007 Financial Results 1642 9Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 1Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 2Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 3Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 4Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 1Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 2Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 3Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 4Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 5Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 6
...WIRE) -- June 14,2007 -- Targeted Genetics Corpor...the dose escalation arm of the ongoing Phase,I/II ...atory,arthritis. Philip J. Mease, M.D., clinical p... Medicine, chief of rheumatology,clinical research...an with Seattle Rheumatology Associates and the le...
...- Prolexys,Pharmaceuticals and announced today a p...ive small molecule anti-tumor agent,erastin. Prol...eomics technology to understand the mechanism of a...the June 14, 2007 issue,of the journal Nature reve...pendent anion channels (VDACs) -- a novel target f...
Other Medicine Technology:Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3